Parallel Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $180K | Buy |
2,861
+403
| +16% | +$28.1K | ﹤0.01% | 1232 |
|
|
2025
Q4 | $163K | Buy |
2,458
+826
| +51% | +$53.4K | ﹤0.01% | 1188 |
|
|
2025
Q3 | $110K | Sell |
1,632
-427
| -21% | -$33.8K | ﹤0.01% | 1373 |
|
|
2025
Q2 | $180K | Sell |
2,059
-458
| -18% | -$35.9K | ﹤0.01% | 1060 |
|
|
2025
Q1 | $172K | Sell |
2,517
-195
| -7% | -$15.9K | ﹤0.01% | 1026 |
|
|
2024
Q4 | $211K | Buy |
2,712
+735
| +37% | +$54.4K | ﹤0.01% | 914 |
|
|
2024
Q3 | $133K | Sell |
1,977
-2,047
| -51% | -$168K | ﹤0.01% | 1134 |
|
|
2024
Q2 | $456K | Sell |
4,024
-108
| -3% | -$13.7K | 0.01% | 567 |
|
|
2024
Q1 | $573K | Buy |
4,132
+525
| +15% | +$66K | 0.02% | 496 |
|
|
2023
Q4 | $448K | Buy |
3,607
+1,189
| +49% | +$121K | 0.01% | 526 |
|
|
2023
Q3 | $226K | Sell |
2,418
-396
| -14% | -$44.6K | 0.01% | 737 |
|
|
2023
Q2 | $362K | Buy |
2,814
+65
| +2% | +$7.86K | 0.01% | 567 |
|
|
2023
Q1 | $319K | Sell |
2,749
-378
| -12% | -$42.3K | 0.01% | 589 |
|
|
2022
Q4 | $354K | Buy |
3,127
+764
| +32% | +$83.9K | 0.02% | 504 |
|
|
2022
Q3 | $190K | Buy |
2,363
+679
| +40% | +$57.5K | 0.01% | 697 |
|
|
2022
Q2 | $126K | Sell |
1,684
-664
| -28% | -$60.6K | 0.01% | 876 |
|
|
2022
Q1 | $305K | Sell |
2,348
-56
| -2% | -$6.13K | 0.01% | 577 |
|
|
2021
Q4 | $323K | Buy |
2,404
+100
| +4% | +$14.4K | 0.01% | 579 |
|
|
2021
Q3 | $315K | Buy |
2,304
+564
| +32% | +$71.1K | 0.01% | 553 |
|
|
2021
Q2 | $186K | Buy |
1,740
+348
| +25% | +$33.4K | 0.01% | 708 |
|
|
2021
Q1 | $125K | Sell |
1,392
-472
| -25% | -$44.3K | 0.01% | 797 |
|
|
2020
Q4 | $172K | Sell |
1,864
-956
| -34% | -$85.4K | 0.01% | 641 |
|
|
2020
Q3 | $291K | Buy |
2,820
+1,584
| +128% | +$165K | 0.02% | 436 |
|
|
2020
Q2 | $125K | Sell |
1,236
-144
| -10% | -$12.9K | 0.01% | 681 |
|
|
2020
Q1 | $92K | Sell |
1,380
-112
| -8% | -$6.97K | 0.01% | 705 |
|
|
2019
Q4 | $82K | Buy |
1,492
+528
| +55% | +$25K | 0.01% | 860 |
|
|
2019
Q3 | $36K | Buy |
964
+120
| +14% | +$4.66K | ﹤0.01% | 1108 |
|
|
2019
Q2 | $32K | Hold |
844
| – | – | ﹤0.01% | 1073 |
|
|
2019
Q1 | $25K | Hold |
844
| – | – | ﹤0.01% | 1114 |
|
|
2018
Q4 | $25K | Hold |
844
| – | – | ﹤0.01% | 974 |
|
|
2018
Q3 | $30K | Hold |
844
| – | – | ﹤0.01% | 997 |
|
|
2018
Q2 | $20K | Buy |
844
+292
| +53% | +$6.19K | ﹤0.01% | 1049 |
|
|
2018
Q1 | $10K | Buy |
552
+108
| +24% | +$1.6K | ﹤0.01% | 1254 |
|
|
2017
Q4 | $6K | Hold |
444
| – | – | ﹤0.01% | 1480 |
|
|
2017
Q3 | $6K | Buy |
444
+52
| +13% | +$919 | ﹤0.01% | 1484 |
|
|
2017
Q2 | $7K | Sell |
392
-36
| -8% | -$665 | ﹤0.01% | 1435 |
|
|
2017
Q1 | $8K | Buy |
428
+356
| +494% | +$6.95K | ﹤0.01% | 1303 |
|
|
2016
Q4 | $1K | Buy |
+72
| New | +$1.27K | ﹤0.01% | 1693 |
|
Other funds holding DXCM
VCM
VPM
Parallel Advisors's DXCM Position: Q1 2026 in Review
Parallel Advisors increased its DexCom (DXCM) stake by 16% in Q1 2026, buying an estimated $28.1K and bringing the position to 2,861 shares worth $180K. The position accounts for ﹤0.01% of the portfolio, ranked #1232.
Parallel Advisors first reported a position in DXCM in Q4 2016 and has held it in 38 quarters since. The position peaked at $573K in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Parallel Advisors held 2,861 shares of DexCom worth $180K as of Q1 2026.
- Parallel Advisors bought 403 DexCom shares in Q1 2026, an estimated $28.1K.
- DexCom made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #1232 holding.
- Parallel Advisors first reported a position in DexCom in Q4 2016 and has held it in 38 quarters since.
- Parallel Advisors's DexCom position peaked at $573K in Q1 2024.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.